Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

4articles mentioning institutions

7institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: FDA-approved ×

FDA-approved

This institution is selected. Its supporting articles are shown below.

FDA-approved4

Articles mentioning FDA-approved

4 articles · page 1 of 1

Bladder-sparing strategies for non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure: a systematic review

bmjonc · full text · 2026-02-01 · 4 matching annotations

88.6%

FDA International Bladder Cancer Group NCT FDA-approved

…n launched and their outcomes are awaited. As of June 2025, the FDA has approved valrubicin, pembrolizumab, nadofaragene firadenove…

309 Combining radiopharmaceutical therapy with CAR T cells to overcome the heterogeneous immunosuppressive prostate tumor microenvironment

jitc · abstract · 2025-11-04 · 1 matching annotations

76.1%

NCT03873805 FDA-approved 177Lu-PSMA-617 metastatic castration-resistant prostate cancer metastatic castration-resistant prostate cancer (mCRPC)mCRPC cyclophosphamide Cy RPT

…ication in mCRPC faces challenges. In a phase 1 clinical trial (NCT03873805) evaluating CAR-T cells targeting Prostate Stem Cell Antigen (P…

403 Machine learning-based prediction of adverse events in cancer patients treated with PD-1/PD-L1 inhibitors using FAERS data

jitc · abstract · 2025-11-04 · 1 matching annotations

76.0%

FDA-approved non-small cell lung cancer nivolumab durvalumab tislelizumab atezolizumab pembrolizumab melanoma pneumonitis Immune checkpoint inhibitors

…, Li Y, Qin Z, Saba NF, Teng Y. Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States. J Exp Clin C…

991 Up to one-third of antibody drugs are nonspecific: a systematic evaluation of drugs throughout clinical and preclinical development

jitc · abstract · 2025-11-04 · 1 matching annotations

83.5%

FDA-approved CAR-T FDA

…ned on the MPA. We also produced and screened 83 biosimilars of FDA-approved and clinical-stage therapeutic antibodies.Results Retrospective…